Check-Cap (NASDAQ:MBAI) & Nanovibronix (NASDAQ:FEED) Financial Survey

Nanovibronix (NASDAQ:FEED) and Check-Cap (NASDAQ:MBAI) are both small-cap manufacturing companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares Nanovibronix and Check-Cap’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Check-Cap	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Nanovibronix and Check-Cap, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Check-Cap	1	0	0	0	1.00

Institutional and Insider Ownership

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 1.4% of Nanovibronix shares are held by insiders. Comparatively, 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Nanovibronix has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500.

Valuation & Earnings

This table compares Nanovibronix and Check-Cap”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$2.56 million	0.94	-$3.70 million	($41.74)	-0.05
Check-Cap	N/A	N/A	-$25.15 million	($2.77)	-0.57

Nanovibronix has higher revenue and earnings than Check-Cap. Check-Cap is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Summary

Nanovibronix beats Check-Cap on 6 of the 10 factors compared between the two stocks.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.